At the moment of PMF diagnosis, a poor clinical outcome was not expected, as type 1 CALR mutation is considered a favorable prognostic factor for PMF, although the precise rates of transformation to AML need to be established on large cohorts. Here, CALR is linked to acute myeloid leukemia.